Topic: clinical study experimentals
Are there certain types of clinical sponsors and studies that are at greater risk of experiencing supply challenges?
There are a lot of resources for dealing with slow enrolling studies, but what about challenges with studies that enroll very quickly?
Drugmaker AMAG Pharmaceuticals said it reached key development milestones for two of its pipeline drugs: the subcutaneous autoinjector version of Makena and the anemia drug Feraheme.
China's Jilin Jian Yisheng Biopharma and the U.S. Army Medical Research Institute of Infectious Diseases showed positive animal test results on an Ebola PIKA adjuvant vaccine candidate.